PNC Financial Services Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-302
| Closed | -$11.9K | – | 4833 |
|
|
2023
Q2 | $11.9K | Sell |
302
-4,778
| -94% | -$169K | ﹤0.01% | 3800 |
|
|
2023
Q1 | $124K | Buy |
+5,080
| New | +$111K | ﹤0.01% | 2440 |
|
|
2022
Q2 | – | Sell |
-84
| Closed | -$1K | – | 4814 |
|
|
2022
Q1 | $1K | Buy |
+84
| New | +$1.24K | ﹤0.01% | 4437 |
|
|
2016
Q4 | – | Sell |
-875
| Closed | -$40K | – | 4121 |
|
|
2016
Q3 | $40K | Sell |
875
-156
| -15% | -$8.8K | ﹤0.01% | 2922 |
|
|
2016
Q2 | $53K | Buy |
1,031
+888
| +621% | +$44.1K | ﹤0.01% | 2809 |
|
|
2016
Q1 | $6K | Buy |
143
+5
| +4% | +$255 | ﹤0.01% | 3791 |
|
|
2015
Q4 | $11K | Hold |
138
| – | – | ﹤0.01% | 3566 |
|
|
2015
Q3 | $6K | Sell |
138
-41
| -23% | -$2.17K | ﹤0.01% | 3912 |
|
|
2015
Q2 | $9K | Buy |
179
+80
| +81% | +$3.98K | ﹤0.01% | 3849 |
|
|
2015
Q1 | $5K | Sell |
99
-903
| -90% | -$46.9K | ﹤0.01% | 4032 |
|
|
2014
Q4 | $46K | Buy |
1,002
+924
| +1,185% | +$38.8K | ﹤0.01% | 2831 |
|
|
2014
Q3 | $3K | Sell |
78
-500
| -87% | -$19.6K | ﹤0.01% | 3601 |
|
|
2014
Q2 | $26K | Buy |
578
+244
| +73% | +$8.95K | ﹤0.01% | 2840 |
|
|
2014
Q1 | $12K | Buy |
+334
| New | +$11.3K | ﹤0.01% | 3016 |
|
PNC Financial Services Group's ISEE Position: Q3 2023 in Review
PNC Financial Services Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 302 shares — an estimated $11.9K sold.
PNC Financial Services Group first reported a position in ISEE in Q1 2014 and held it in 14 quarters. The position peaked at $124K in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- PNC Financial Services Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- PNC Financial Services Group sold 302 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $11.9K.
- PNC Financial Services Group first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 14 quarters.
- PNC Financial Services Group's IVERIC bio, Inc. Common Stock position peaked at $124K in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on PNC Financial Services Group's 13F filing for Q3 2023, filed 13 Nov 2023.